Antibacterial Polyene Pigment from Mycena
Journal of Natural Products, 2010, Vol. 73, No. 8 1353
(1:1, 5 mL), prepurified with an RP-18 cartridge, and separated on an
RP-18 column by preparative HPLC (UV/vis detection at 420 nm),
yielding 1 (3.5 mg, tR 42.0 min).
Synthetic R-6: GC-MS (Betadex 120) Ri 1688; m/z (see mass
spectrum of S-6).
Determination of the Absolute Configuration at C-25 of 1:
Degradation of Mycenaaurin A (1) to Methyl (R)-3-Hydroxybu-
tanoate (R-7). Ozone was passed through a solution of 6 mg (9 µmol)
of 1 in 5 mL of MeOH-DMSO (10:1) at -78 °C for 2 min. After
addition of three drops of 30% H2O2 the solution was allowed to warm
to room temperature and the solvents were removed. The residue was
refluxed in 2 mL 1 N methanolic KOH for 8 h; then the solvent was
removed and the residue was dissolved in H2O, acidified with aqueous
HCl, and extracted three times with EtOAc. The organic phase was
dried over Na2SO4, filtered, and concentrated in vacuo. The aqueous
phase was neutralized with aqueous NaOH, and the solvent was
evaporated. Both the organic and the aqueous phases were dissolved
in 1 mL of EtOAc and methylated for 15 min with an ethereal solution
of CH2N2. The solutions were dried over Na2SO4, filtered and
concentrated in vacuo, transferred into GC vials, and analyzed by
enantioselective GC-MS. The product (7) could be found only in traces
in the aqueous phase. Compound 7 consisted mainly of R-7, but some
S-7 was also present, which we attributed to partial racemization of
R-7 during the degradation procedure. GC-MS (Lipodex E) Ri 1237;
m/z (%) 103 (43) [M - CH3]+, 100 (5) [M - H2O]+, 87 (34), 74 (90)
[M - CH3CHO]+, 71 (44), 61 (18), 59 (18) [CO2CH3]+, 45 (48) [M -
CH2CO2CH3]+, 43 (100) [CH3CO]+.
Mycenaaurin A (1): orange solid; UV/vis (MeOH) λmax (log ε) 202
(4.51), 226 (4.55), 264 (4.24), 334 (4.48), 400 (4.95), 417 (5.03), 436
(4.94) nm; 1H NMR (see Table 1); 13C NMR (see Table 1); HRAPCIMS
m/z 669.3384 (calcd for C36H49N2O10 [M + H]+, 669.3382); HRAPCI-
MSMS (parent ion m/z 669, 35 eV) m/z (%) 651.3287 (95) [C36H47N2O9,
M + H - H2O]+, 508.2700 (100) [C30H38NO6, M + H -
HO(CH2)2CH(NHCOCH3)(CO2H)]+, 490.2592 (39) [C30H36NO5]+.
Determination of the Absolute Configuration at C-2′ of 1:
Degradation and Derivatization of 1 to (S)-Dimethyl 2-((R)-3,3,3-
Trifluoro-2-methoxy-2-phenylpropanamido)pentanedioate (2S,2′R-5).
Ozone was passed through a solution of 1.7 mg (2.6 µmol) of
mycenaaurin A (1) in 2 mL of MeOH at -78 °C for 1 min. After
addition of two drops of 30% H2O2 the solution was allowed to warm
to room temperature and the solvents were removed. The residue was
refluxed in 2 mL of MeOH and 0.2 mL of (CH3)3SiCl for 1 h. After
complete removal of the solvent, the residue was dissolved in 0.5 mL
of pyridine. Then, 3 µL (16 µmol) of (S)-3,3,3-trifluoro-2-methoxy-
2-phenylpropanoic acid chloride (S-MTPA-Cl) and catalytic amounts
of 4-dimethylaminopyridine (DMAP) were added, and the solution was
stirred under argon at 37 °C for 1 h. The solvent was removed and the
residue was dissolved in 1 mL of H2O and extracted three times with
1 mL of CHCl3. The organic phase was dried over Na2SO4, filtered,
concentrated under reduced pressure, and transferred into a GC vial.
2S,2′R-5: GC-MS Ri 2190; m/z (%) 328 (4), 202 (26) [M -
C(CF3)(OCH3)(C6H5)]+, 189 (76) [C(CF3)(OCH3)(C6H5)]+, 174 (67)
[M - (CdO)C(CF3)(OCH3)(C6H5)]+, 170 (30), 158 (8), 142 (100) [M
- C(CF3)(OCH3)(C6H5) - CO - CH3OH]+, 139 (13), 127 (14), 119
(19), 114 (20), 110 (29), 105 (45) [C7H5O]+, 98 (14), 91 (24), 82 (21),
77 (33) [C6H5]+, 69 (9) [CF3]+.
Synthetic R-7. Sodium (R)-3-hydroxybutanoate was acidified with
10 N HCl, and the free carboxylic acid was extracted with EtOAc.
The organic phase was dried over Na2SO4, filtered, concentrated in
vacuo, and methylated for 10 min with an ethereal solution of CH2N2.
The solution was dried over Na2SO4, filtered and concentrated in vacuo,
transferred into a GC vial, and analyzed by enantioselective GC-MS.
1H NMR (250 MHz, CDCl3, 300 K) δ 4.17 (m, 1 H, H-3), 3.68 (s, 3
3
H, H-1′), 2.45 (m, 2 H, H-2), 1.20 (d, JHH ) 6.3 Hz, 3 H, H-4); 13C
NMR (63 MHz, CDCl3, 300 K) δ 173.2 (C-1), 64.2 (C-3), 51.7 (C-1′),
42.5 (C-2), 22.4 (C-4); GC-MS (Lipodex E) Ri 1239; m/z (%) 117 (2),
103 (46) [M - CH3]+, 100 (7) [M - H2O]+, 87 (35), 85 (10), 74 (100)
[M - CH3CHO]+, 71 (46), 61 (17), 59 (15) [CO2CH3]+, 45 (47) [M -
CH2CO2CH3]+, 43 (98) [CH3CO]+.
Synthetic S-7: GC-MS (Lipodex E) Ri 1214; m/z (see mass spectrum
of synthetic R-7).
Synthetic 2S,2′R-5: Synthetic 2S,2′R-5 was synthesized from
L-glutamic acid by methylation and reaction with S-MTPA-Cl as
described above: GC-MS Ri 2192; m/z (%) 328 (6), 202 (27) [M -
C(CF3)(OCH3)(C6H5)]+, 189 (44) [C(CF3)(OCH3)(C6H5)]+, 174 (66)
[M - (CdO)C(CF3)(OCH3)(C6H5)]+, 170 (19), 158 (7), 142 (100) [M
- C(CF3)(OCH3)(C6H5) - CO - CH3OH]+, 139 (6), 127 (6), 119 (10),
114 (17), 110 (28), 105 (19) [C7H5O]+, 98 (11), 91 (9), 82 (19), 77 (9)
[C6H5]+, 69 (4) [CF3]+.
Determination of the Absolute Configuration at C-2′′ of 1:
Degradation and Derivatization of 1 to (S)-Methyl 2-((R)-3,3,3-
Trifluoro-2-methoxy-2-phenylpropanamido)-4-hydroxybutanoate
(2S,2′R-8). Ozone was passed through a solution of 1.73 mg (2.59 µmol)
of 1 in 2 mL of MeOH at -78 °C for 1 min. Two drops of 30% H2O2
were added, the solution was allowed to warm to room temperature,
and the solvents were removed. The residue was refluxed in 1 mL of
concentrated HCl for 1 h. After removal of the solvent the residue was
refluxed in 2 mL of MeOH and 0.2 mL of (CH3)3SiCl for 1 h. The
solvent was removed, and the residue was dissolved in 0.5 mL of
pyridine. After addition of 3 µL (16 µmol) of S-MTPA-Cl and catalytic
amounts of DMAP the solution was stirred under argon at 37 °C for
1 h. The solvent was removed, and the residue was dissolved in 1 mL
of H2O and extracted three times with 1 mL of CHCl3. The organic
phase was dried over Na2SO4, filtered, concentrated under reduced
pressure, and transferred into a GC vial. GC-MS Ri 2056; m/z (%) 318
(7) [M - CH3O]+, 189 (84) [C(CF3)(OCH3)(C6H5)]+, 188 (35), 175
(14), 170 (22), 160 (85) [M - C(CF3)(OCH3)(C6H5)]+, 156 (34), 139
(13), 128 (59), 119 (24), 113 (35), 105 (57) [C7H5O]+, 97 (12), 91
(30), 86 (37), 77 (39) [C6H5]+, 69 (20) [CF3]+, 44 (36), 40 (100).
Synthetic 2S,2′S-8. Compound 2S,2′S-8 was synthesized from
L-homoserine by methylation and reaction with R-MTPA-Cl as
described above: GC-MS Ri 2042; m/z (%) 318 (2) [M - CH3O]+,
190 (35), 189 (100) [C(CF3)(OCH3)(C6H5)]+, 188 (25), 175 (19), 170
(80), 160 (59) [M - C(CF3)(OCH3)(C6H5)]+, 156 (20), 139 (18), 128
(77), 119 (28), 105 (68) [C7H5O]+, 100 (19), 91 (36), 86 (27), 77 (48)
[C6H5]+, 69 (13) [CF3]+.
Synthetic 2S,2′S-5. Synthetic 2S,2′S-5 was synthesized from L-
glutamic acid by methylation and reaction with R-MTPA-Cl as
described above. GC-MS Ri 2175; m/z (see mass spectrum of synthetic
2S,2′R-5).
Determination of the Absolute Configuration at C-19 of 1:
Degradation and Derivatization of 1 to Methyl 2-((R)-Tetrahydro-
5-oxofuran-2-yl)acetate (R-6). Ozone was passed through a solution
of 12 mg (18 µmol) of 1 in 5 mL of MeOH at -78 °C for 1 min. Two
drops of 30% H2O2 were added, the solution was allowed to warm to
room temperature, and the solvents were removed. The residue was
methylated for 15 min in an ethereal solution of CH2N2, and the solvent
was evaporated under reduced pressure. The residue was warmed to
50 °C in 2 N HCl for 10 min and after removal of the solvent methylated
again for 15 min in an ethereal solution of CH2N2. The reaction product
was concentrated in vacuo, transferred into a GC vial, and analyzed
by enantioselective GC-MS.
R-6: GC-MS (Betadex 120) Ri 1688; m/z (%) 140 (18) [M - H2O]+,
130 (17) [M - CO]+, 127 (19), 126 (11), 116 (11), 98 (11), 85 (100)
[M - CH2CO2CH3]+, 74 (15), 59 (13) [CO2CH3]+, 57 (13), 56 (16),
55 (19), 43 (20).
Synthetic S-6. Compound S-6 was synthesized from 1-tert-butyl
6-methyl 3-oxohexanedioate, which was reduced enzymatically with
baker’s yeast.11,12 For NMR measurements the reaction product was
purified by flash chromatography [silica gel, hexane-EtOAc (2:1)],
1
yielding an enantiomeric mixture of the lactones R- and S-6 (1:4): H
NMR (500 MHz, CDCl3, 300 K) δ 4.89 (m, 1 H, H-2), 3.71 (s, 3 H,
H-1′′), 2.82 (dd, 3JHH ) 6.6 Hz, 2JHH ) 16.3 Hz, 1 H, Ha-2′), 2.65 (dd,
3JHH ) 6.4 Hz, 2JHH ) 16.3 Hz, 1 H, Hb-2′), 2.57 (m, 2 H, H-4), 2.47
(m, 1 H, Ha-3), 1.97 (m, 1 H, Hb-3); 13C NMR (126 MHz, CDCl3, 300
K) δ 176.4 (C-5), 169.9 (C-1′), 76.2 (C-2), 52.0 (C-1′′), 39.7 (C-2′),
28.4 (C-4), 27.6 (C-3); GC-MS (Betadex 120) Ri 1685; m/z (%) 140
(18) [M - H2O]+, 130 (17) [M - CO]+, 127 (18), 126 (10), 116 (10),
108 (8), 98 (9), 85 (100) [M - CH2CO2CH3]+, 74 (13), 59 (11)
[CO2CH3]+, 56 (13), 55 (18), 54 (7), 43 (13).
Synthetic 2S,2′R-8. Compound 2S,2′R-8 was synthesized from
L-homoserine by methylation and reaction with S-MTPA-Cl as de-
scribed above: GC-MS Ri 2055; m/z (%) (see mass spectrum of 2S,2′S-
8).
Biological Tests. For agar diffusion assays, 1 (0.5 µmol) was
dissolved in MeOH (5-25 µL) and dropped onto paper discs (diameter
5 mm, thickness 0.5 mm). These discs were dried under sterile
conditions and placed on agar plates inoculated with the test organism